Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.
2.
3.

TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.

Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massagué J.

Nat Cell Biol. 2001 Apr;3(4):400-8.

PMID:
11283614
4.

Fusion proteins of retinoid receptors antagonize TGF-beta-induced growth inhibition of lung epithelial cells.

La P, Morgan TA, Sykes SM, Mao H, Schnepp RW, Petersen CD, Hua X.

Oncogene. 2003 Jan 16;22(2):198-210.

PMID:
12527889
5.

Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).

Pardali K, Kowanetz M, Heldin CH, Moustakas A.

J Cell Physiol. 2005 Jul;204(1):260-72.

PMID:
15690394
6.

Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.

Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ.

Clin Cancer Res. 2002 Nov;8(11):3628-38.

7.

Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

Pardali K, Kurisaki A, Morén A, ten Dijke P, Kardassis D, Moustakas A.

J Biol Chem. 2000 Sep 22;275(38):29244-56.

8.

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB.

J Biol Chem. 2001 Jun 8;276(23):19945-53. Epub 2001 Mar 21.

10.

Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.

Guda K, Giardina C, Nambiar P, Cui H, Rosenberg DW.

Mol Carcinog. 2001 Aug;31(4):204-13.

PMID:
11536370
11.

Integrating Myc and TGF-beta signalling in cell-cycle control.

Amati B.

Nat Cell Biol. 2001 May;3(5):E112-3. No abstract available.

PMID:
11331894
14.

Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling.

Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA.

Mol Cell. 1999 Oct;4(4):499-509.

15.

Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site.

Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF.

J Biol Chem. 1995 Nov 10;270(45):26750-3.

16.

Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.

Li C, Zhu NL, Tan RC, Ballard PL, Derynck R, Minoo P.

J Biol Chem. 2002 Oct 11;277(41):38399-408. Epub 2002 Aug 2.

17.

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

Villanueva A, García C, Paules AB, Vicente M, Megías M, Reyes G, de Villalonga P, Agell N, Lluís F, Bachs O, Capellá G.

Oncogene. 1998 Oct 15;17(15):1969-78.

18.

Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.

Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K.

Oncogene. 2004 Mar 4;23(9):1656-67.

PMID:
15001984
19.

Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.

Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sugano Y, Yamashiki N, Nakagawa T, Seki T, Nishizawa M, Fujisawa J, Inoue K.

Hepatology. 2000 Aug;32(2):218-27.

PMID:
10915727
20.

Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.

Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, Tararak E, Bobik A.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1391-6. Epub 2004 May 27.

Items per page

Supplemental Content

Write to the Help Desk